Jing Zhuang | Oncology | Best Researcher Award

Posted on by Forensic Scientist

Ms. Jing Zhuang | Oncology | Best Researcher Award

Huzhou Central Hospital | China

Zhuang Jing is a dedicated head nurse at Huzhou Central Hospital with a master’s degree in nursing. She plays a pivotal role in the Zhejiang-France United Laboratory of Integrated Traditional Chinese and Modern Medicine in Colorectal Cancer and the Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer of Huzhou. Her research focuses on digestive tumors and intestinal microecology, contributing significantly to clinical advancements and patient care.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

🎗️ Zhuang Jing has demonstrated a remarkable commitment to advancing research in colorectal cancer with a focus on intestinal microecology. As a leading member of the Zhejiang-France United Laboratory and the Key Laboratory of Multiomics Research and Clinical Transformation of Digestive Cancer, her involvement in 36 research projects and authorship of over 50 SCI-indexed publications reflect her substantial contribution to the field. Additionally, her work’s impact is evidenced by an H-index of 13 and two patents, showcasing both innovation and scientific rigor. These achievements align well with the criteria for a “Best Researcher Award.”

Education 🎓

Zhuang Jing holds a master’s degree in nursing, equipping her with advanced knowledge and skills to excel in clinical and research settings. Her academic background has provided a solid foundation for her pursuits in oncology and digestive cancer research.

Experience 💼

As the head nurse at Huzhou Central Hospital, Zhuang Jing has extensive experience in patient care, research coordination, and multidisciplinary collaboration. She is a key member of international research initiatives, particularly in colorectal cancer studies, where she integrates traditional Chinese and modern medical practices.

Research Interests On Oncology🔬

Her primary research interests lie in digestive tumors and intestinal microecology. Zhuang focuses on exploring the relationship between gut health and cancer, aiming to develop innovative therapeutic strategies for colorectal cancer.

Awards 🏆

Zhuang Jing’s contributions to oncology and nursing have earned her recognition in the medical community. She is currently nominated for the Best Researcher Award at the Forensic Scientist Awards, acknowledging her outstanding achievements in digestive cancer research.

Publications 📚

  1. Gut microbial subtypes and clinicopathological value for colorectal cancer

    • Authors: Shuwen Han, Jing Zhuang, Yifei Song, Xinyue Wu, Xiaojian Yu, Ye Tao, Jian Chu, Zhanbo Qu, Yinhang Wu, Shugao Han et al.

    • Year: 2024

  2. Trace elements in pancreatic cancer

    • Authors: Yao Yanjun, Zhuang Jing, Song Yifei, Gu Gangzhao, Yan Chenxin, Wei Qiang, Yan Qiang, Han Shuwen

    • Year: 2024

  3. Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T‐cell costimulator as a crucial immune checkpoint molecule

    • Authors: Jian Chu, Yinghang Wu, Zhanbo Qu, Jing Zhuang, Jiang Liu, Shugao Han, Wei Wu, Shuwen Han

    • Year: 2024

  4. Aging characteristics of colorectal cancer based on gut microbiota

    • Authors: Yinhang Wu, Jing Zhuang, Qi Zhang, Xingming Zhao, Gong Chen, Shugao Han, Boyang Hu, Wei Wu, Shuwen Han

    • Year: 2023

  5. Developing a Diagnostic Model to Predict the Risk of Asthma Based on Ten Macrophage‐Related Gene Signatures

    • Authors: Xiaoshun Ai, Hong Shen, Yangyanqiu Wang, Jing Zhuang, Yani Zhou, Furong Niu, Qing Zhou, Si Qin

    • Year: 2022

  6. Screening of T Cell-Related Long Noncoding RNA-MicroRNA-mRNA Regulatory Networks in Non-Small-Cell Lung Cancer

    • Authors: Jing Zhuang

    • Year: 2020

  7. Analysis of T lymphocyte-related biomarkers in pancreatic cancer

    • Authors: Jing Zhuang

    • Year: 2020

  8. Progress in Research on Colorectal Cancer-Related Microorganisms and Metabolites

    • Authors: Jing Zhuang

    • Year: 2020

  9. Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression

    • Authors: Jing Zhuang

    • Year: 2020

  10. Biological roles of piRNAs in colorectal cancer

  • Authors: Jing Zhuang

  • Year: 2020

  1. Predicting biomarkers from classifier for liver metastasis of colorectal adenocarcinomas using machine learning models

  • Authors: Jing Zhuang

  • Year: 2020

  1. Biological significance of piRNA in liver cancer: a review

  • Authors: Jing Zhuang

  • Year: 2020

Conclusion 🔖

Zhuang Jing’s commitment to advancing colorectal cancer research through the lens of intestinal microecology has made her a prominent figure in the field. Her extensive publication record, clinical expertise, and dedication to improving patient outcomes exemplify her remarkable contributions to healthcare and medical research.

Yuchun Wei | Oncology | Best Researcher Award

Posted on by Forensic Scientist

Assoc. Prof. Dr. Yuchun Wei | Oncology | Best Researcher Award

Shandong Cancer Hospital | China

Dr. Yuchun Wei is a distinguished oncology researcher and radiotherapy physician at Shandong Cancer Hospital, China. Her work focuses on developing new imaging biomarkers for cancer detection, biological characterization, staging, and individualized therapy planning. With a deep commitment to advancing medical imaging, Dr. Wei’s research explores innovative imaging methods to improve cancer diagnostics and treatment.

Professional profile👤

Scopus

Strengths for the Awards✨

  • 🌟 Exceptional Research Contributions: Dr. Wei has an impressive record of high-impact publications in prestigious journals like Radiology (IF=19.7), J Nucl Med (IF=11.082), and Eur J Nucl Med Mol Imaging (IF=10.057), reflecting the quality and significance of her work.

  • 🔬 Pioneering Work in Imaging Biomarkers: Her research focuses on developing new imaging methods for cancer detection, prognosis, and treatment monitoring, demonstrating innovation and addressing critical needs in oncology.

  • 📈 Leadership Roles: Experience as Deputy Director and Assistant Director at Shandong Cancer Hospital highlights her leadership in clinical and research settings.

  • 👩‍🏫 Collaborative Impact: Contributions as a corresponding and co-corresponding author in multiple papers underscore her role in guiding research teams.

  • 🏆 Recognition of Excellence: Consistent publication in top-tier journals (Q1) across diverse aspects of nuclear medicine and oncology points to widespread recognition in her field.

🎓 Education

  • Ph.D. in Oncology (2018.09-2022.06) – Shandong University, under the mentorship of Jinming Yu (Academician of Chinese Academy of Engineering).
  • Master’s in Oncology (2013.09-2016.06) – Jinan University, mentored by Shuanghu Yuan.
  • Bachelor’s in Traditional Chinese and Western Medicine Clinical (2007.09-2012.06) – Shandong University of Traditional Chinese Medicine.

💼 Experience

  • 🔺 Deputy Director (2021.09-2022.08) – MDT Quality Management Office, Shandong Cancer Hospital.
  • Radiotherapy Physician (2017.07-Present) – Shandong Cancer Hospital.
  • Assistant Director (2020.12-2021.08) – Radioimmunity and Molecular Imaging Room, Shandong Cancer Hospital.

🔮 Research Interests On Oncology

Dr. Wei’s research delves into new imaging techniques for cancer detection and treatment evaluation. Her primary focus is on developing prognostic and predictive imaging biomarkers, enhancing individualized therapy planning, and monitoring cancer progression.

🏆 Awards

  • Recognition for contributions to cancer imaging and personalized therapy at Shandong Cancer Hospital.

📝 Publications

  • Title: FAPI Compared with FDG PET/CT for Diagnosis of Primary and Metastatic Lung Cancer
    Authors: Wei Yuchun#, Ma Li, Li Pei, Lu Jie, Ren Jiazhong, Yan Shoumei, Wu Hongbo, Yuan Shuanghu, Fu Zheng, Yu Jinming
    Year: 2023
    Citations: Radiology, 308(2):e222785. (JCR Q1, IF=19.7)

  • Title: [18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
    Authors: Yinjun Dong#, Zhendan Wang#, Xinying Hu, Yuhong Sun, Jingjie Qin, Qiming Qin, Shuguang Liu, Shuanghu Yuan, Jinming Yu, Yuchun Wei* (Corresponding author)
    Year: 2024
    Citations: J Nucl Med. (JCR Q1, IF=9.1)

  • Title: Early Detection of Radiation-Induced Myocardial Damage by [18F]AlF-NOTA-FAPI-04 PET/CT Imaging
    Authors: Wei Yuchun#, Sun Y, Liu J, Zhang G, Qin X, Xu S, Wang S, Tao Y, Pei J, Yu J
    Year: 2023
    Citations: Eur J Nucl Med Mol Imaging, 50(2):453-464. (JCR Q1, IF=10.057)

  • Title: Response Prediction Using 18F-FAPI-04 PET/CT in Patients with Esophageal Squamous Cell Carcinoma Treated with Concurrent Chemoradiotherapy
    Authors: Hu X, Zhou T, Ren J, Duan J, Wu H, Liu X, Mu Z, Liu N, Wei Yuchun* (Co-corresponding author), Yuan ST*
    Year: 2023
    Citations: J Nucl Med, 64(4):625-631. (JCR Q1, IF=11.082)

  • Title: [18F]AlF‑NOTA‑FAPI‑04: FAP‑targeting Specificity, Biodistribution, and PET/CT Imaging of Various Cancers
    Authors: Wei Yuchun#, Zheng Jinsong, Ma Li, Liu Xiaoli, Xu Shengnan, Wang Shijie, Pei Jinli, Cheng Kai, Yuan Shuanghu, Yu Jinming
    Year: 2022
    Citations: Eur J Nucl Med Mol Imaging, 49(8):2761-2773. (JCR Q1, IF=10.057)

  • Title: [18F]AlF‑NOTA‑FAPI‑04 PET/CT Uptake in Metastatic Lesions on PET/CT Imaging Might Distinguish Different Pathological Types of Lung Cancer
    Authors: Wei Yuchun#, Cheng Kai#, Fu Zheng, Zheng Jinsong, Mu Zhengshuai, Zhao Chenglong, Liu Xiaoli, Wang Shijie, Yu Jinming, Yuan Shuanghu
    Year: 2022
    Citations: Eur J Nucl Med Mol Imaging, 49(5):1671-1681. (JCR Q1, IF=10.057)

  • Title: Tumor Angiogenesis at Baseline Identified by 18F-Alfatide II PET/CT May Predict Survival Among Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
    Authors: Wei Yuchun#, Qin Xueting, Liu Xiaoli, Zheng Jinsong, Luan Xiaohui, Zhou Yue, Yu Jinming, Yuan Shuanghu
    Year: 2022
    Citations: J Transl Med, 20(1):63-72. (JCR Q2, IF=8.44)

  • Title: Value of [18F]AlF‑NOTA‑FAPI‑04 PET/CT for Differential Diagnosis of Malignant and Various Inflammatory Lung Lesions: Comparison with [18F]FDG PET/CT
    Authors: Kailin Qiao, Xueting Qin, Shuai Fu, Jiazhong Ren, Jing Jia, Xinying Hu, Yuanyuan Tao, Shuanghu Yuan, Yuchun Wei (Corresponding author)
    Year: 2023
    Citations: Eur Radiol. (JCR Q1, IF=5.9)

  • Title: Stereotactic Comparison Study of 18F-Alfatide and 18F-FDG PET Imaging in an LLC Tumor-Bearing C57BL/6 Mouse
    Authors: Wei Yuchun# et al.
    Year: 2016
    Citations: Sci Rep, 6:28757. (JCR Q1, IF=5.228)

  • Title: Diagnostic Value of 18F-NOTA-FAPI PET/CT in a Rat Model of Radiation-Induced Lung Damage
    Authors: Xueting Qin, Shijie Wang, Xiaoli Liu, Jinghao Duan, Kai Cheng, Zhengshuai Mu, Jing Jia, Yuchun Wei (Co-corresponding author), Shuanghu Yuan
    Year: 2022
    Citations: Front Oncol, 12:879281. (JCR Q2, IF=5.738)

📅 Conclusion

Dr. Yuchun Wei is a leading figure in oncology and molecular imaging, dedicated to developing cutting-edge imaging techniques to revolutionize cancer diagnosis and treatment. Her contributions have significantly advanced the field of individualized cancer therapy, making her a standout candidate for this award.